Art Malian
About Art Malian
Art Malian is the Executive Director of IT and Head of Cell Therapy Digital Platform at Bristol Myers Squibb, with extensive experience in IT management and digital health solutions.
Exec Director It at Bristol Myers Squibb
Art Malian currently holds the position of Exec Director IT at Bristol Myers Squibb where he leads the Cell Therapy Digital Platform. His role encompasses overseeing the entire cell therapy patient treatment process, which includes patient enrollment, the manufacture, and the administration of finished drug products. Malian is also responsible for multiple clinical and commercial products manufactured across various sites and countries.
Previous Roles in IT Leadership
Before joining Bristol Myers Squibb, Art Malian held significant IT leadership positions at various companies. From 2014 to 2020, he was the Senior Director IT, Data Management Services, at Celgene, where he managed BI, MDM, Data Integration, and Search. Prior to that, he was the Senior Director IT, Sales and Marketing Solutions, at Pinnacle Foods Corporation from 2012 to 2014. Earlier, Malian worked at Pfizer in multiple roles, including Director of Business Intelligence, and Associate Director of IS Business Intelligence, Sales, and Sales Planning from 2001 to 2012. He started his career with roles at Merck, Schindler Elevator Co, and Pattern Systems International.
Education and Mechanical Engineering Background
Art Malian studied at the New Jersey Institute of Technology, where he earned a Bachelor of Science in Mechanical Engineering (BSME). His academic journey began at Montville High School, laying the foundation for his subsequent career in IT and engineering.
Expertise in Cell Therapy and CPG IT Solutions
Art Malian has extensive expertise in managing IT solutions for both Cell Therapy and Consumer Packaged Goods (CPG) companies. At Bristol Myers Squibb, he leads a GMP controlled and validated Cell Therapy Digital Platform and is deeply involved in leveraging advanced data analytics to optimize clinical trial designs and improve the efficiency of drug development processes.
Global Collaborations and Digital Health Solutions
Art Malian is actively engaged in global collaborations with academic institutions and research organizations to accelerate the discovery and development of new therapies. He works on implementing digital health solutions to enhance patient care and treatment outcomes. Malian also contributes to addressing health disparities in cancer care among minority populations through initiatives by the Bristol Myers Squibb Foundation, promoting health equity and improving health outcomes.